Neolife SA Financials
| ALNLF Stock | EUR 0.06 0 5.71% |
Neolife |
Understanding current and past Neolife SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Neolife SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Neolife SA's assets may result in an increase in income on the income statement.
Neolife SA Stock Summary
Neolife SA competes with Prodways Group, Claranova, DBV Technologies, Manitou BF, and Ossiam Minimum. Its solutions enable architects, landscapists, design offices, and building technicians to meet environmental specification packages for HQE , BREEAM, and LEED projects for individual and multi-unit housing, commercial buildings, and urban spaces. The company was incorporated in 2012 and is headquartered in Limonest, France. Neolife SA is traded on Paris Stock Exchange in France.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0011636083 |
| Business Address | 304 route nationale |
| Sector | Professional Services |
| Industry | Industrials |
| Benchmark | Dow Jones Industrial |
| Website | www.neolife.fr |
| Phone | 33 4 78 25 63 08 |
| Currency | EUR - Euro |
You should never invest in Neolife SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Neolife Stock, because this is throwing your money away. Analyzing the key information contained in Neolife SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Neolife SA Key Financial Ratios
Neolife SA's financial ratios allow both analysts and investors to convert raw data from Neolife SA's financial statements into concise, actionable information that can be used to evaluate the performance of Neolife SA over time and compare it to other companies across industries.| Return On Equity | -0.33 | |||
| Return On Asset | -0.0484 | |||
| Number Of Employees | 19 | |||
| Beta | 2.3 | |||
| Z Score | 1.6 |
Neolife Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Neolife SA's current stock value. Our valuation model uses many indicators to compare Neolife SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neolife SA competition to find correlations between indicators driving Neolife SA's intrinsic value. More Info.Neolife SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Neolife SA's earnings, one of the primary drivers of an investment's value.Neolife SA Systematic Risk
Neolife SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Neolife SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Neolife SA correlated with the market. If Beta is less than 0 Neolife SA generally moves in the opposite direction as compared to the market. If Neolife SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Neolife SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Neolife SA is generally in the same direction as the market. If Beta > 1 Neolife SA moves generally in the same direction as, but more than the movement of the benchmark.
Neolife SA November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Neolife SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neolife SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neolife SA based on widely used predictive technical indicators. In general, we focus on analyzing Neolife Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neolife SA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 14.97 | |||
| Value At Risk | (4.29) | |||
| Potential Upside | 4.33 |
Additional Tools for Neolife Stock Analysis
When running Neolife SA's price analysis, check to measure Neolife SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neolife SA is operating at the current time. Most of Neolife SA's value examination focuses on studying past and present price action to predict the probability of Neolife SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neolife SA's price. Additionally, you may evaluate how the addition of Neolife SA to your portfolios can decrease your overall portfolio volatility.